go to contents

THT BIOMATERIALS GmbH

Back to list

Facts

Founded
2020
Staff
3
Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Focus
consumables / reagents

Profile

THT Biomaterials GmbH aims to overcome major methodological issues at the bottom of today’s drug development, tissue engineering and regenerative medicine research practices leading to false positive or negative results. A new visionary platform technology is under development that will speed up research as it makes its results more realistic by replacing animal components with human components (https://tht-biomaterials.com).

R&D:In vitro toxicoty, in vitro diagnostics (cancer)/drug development. Bioaktive tissue-ink. 2D coating/3D gel. Organoids. Filler and wound healing.

Production:HUMAN PLACENTA Collagen-I, liquid or freece-dried. HUMAN PLACENTA Laminin-111. HUMAN PLACENTA Substrate (hpS).

Similar companies in RDM biotech/pharma

Arthro Kinetics Biotechnology GmbH

Organization type
RDM biotech/pharma
Region
Lower Austria
Cluster
ecoplus
Focus
human health / animal health
Details

F4 Pharma GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Myelopro Diagnostic and Research GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

HeartBeat.bio AG

Organization type
RDM biotech/pharma
Region
Vienna
Focus
human health
Details

Contact

Dr.-Bohr-Gasse 7
1030 Wien
Vienna

Contact: Johannes Hackethal (CTO)
Email: office@tht-biomaterials.com
Website